Receive our newsletter – data, insights and analysis delivered to you
September 26, 2011

FDA urges epinephrine inhaler users to switch to replacement medication

The US Food and Drug Administration (FDA) has said that users of epinephrine inhalers containing chlorofluorocarbons should switch to a replacement product, as these inhalers will not be made or sold after 31 December 2011.

By admin-demo

The US Food and Drug Administration (FDA) has said that users of epinephrine inhalers containing chlorofluorocarbons should switch to a replacement product, as these inhalers will not be made or sold after 31 December 2011.

The move follows efforts to comply with obligations made under the Montreal Protocol on Substances that Deplete the Ozone Layer.

Epinephrine inhalers, marketed by Armstrong Pharmaceutical under the trade name Primatene Mist, are the only FDA-approved prescription-free inhalers for the temporary relief of mild asthma symptoms.

The product uses chlorofluorocarbons to propel the medicine out of the inhaler so that consumers can breathe it into their lungs.

FDA Center for Drug Evaluation and Research Division of Pulmonary, Allergy and Rheumatology Products director Badrul Chowdhury said that anyone who relies on an over-the-counter inhaler to relieve asthma symptoms, should contact a healthcare professional to obtain a replacement medication to treat asthma.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management